Impact

Towards more personalised and data-driven stroke care
Short term
During the project

CEREBRIS is researching new ways to understand how people recover movement and sensation after a stroke. By studying brain scans, brain activity and movement alongside clinical assessments, researchers aim to build a clearer picture of how recovery develops over time.

The project will develop and test tools that use artificial intelligence to identify patterns in this information. Early studies will explore the safety, accuracy and reliability of assessment technologies and investigate which measurements may help predict recovery.

These activities will help establish the scientific and technological foundations for more objective stroke assessment, prediction and monitoring, while strengtheing collaboration across research, clinical and innovation communities.

The project is also expected to create new employment and research opportunities, with at least 30 new recruits anticipated across the consortium by the end of the project.
Long term
The impact ahead

The longer-term aim is to help healthcare professionals tailor care and rehabilitation to each person’s recovery needs. For patients, this could mean support that better reflects their individual difficulties, with the ambition of improving independence in everyday activities, quality of life and participation in family and community life.

More consistent assessments and better-informed care planning could also help healthcare teams use their time and resources more effectively and support patients as they move from hospital to care in the community.

Looking beyond the project, a dedicated spin-out company will be established and led by the Project Coordinator to carry the CEREBRIS technologies forward towards clinical use. It will lead further clinical validation, regulatory planning and commercial development, building on the project's multimodal AI, portable assessment tools and secure data infrastructure. Critically, these would provide the foundation to expand into future applications in other neurological conditions.

THE CEREBRIS CARE PATHWAY

From point of care to better outcomes

Connecting clinical care, intelligent tools and each person’s recovery needs.

01ASSESS & UNDERSTAND

Intelligent Diagnostics

Comprehensive biomarkers from multiple sources to build a clearer picture of each patient’s needs compared to what’s available.

Clinical assessmentPatient data
02CONNECT & SUPPORT

Care system

Data-driven clinical decision making with CEREBRIS tools to tailor the right treatment options, early.

Up to25%

Potential reduction in stroke care costs

03PERSONALISE & EMPOWER

Better outcomes
for patients

More personalised care and better-informed support for recovery, with the ambition of improving independence and quality of life.

Up to 35%

projected improvement in quality of life

The technologies described on this page are under research and development as part of the CEREBRIS project. The technologies described are not yet CE-marked or FDA-cleared, and have not received healthcare payer coverage or reimbursement in any jurisdiction. They are not available for sale and have not been proven safe or effective for the uses described. Projected figures (including cost and quality-of-life estimates) are illustrative research targets, and do not reflect clinical or real-world outcomes. Further validation and regulatory review are required before any CEREBRIS tool could be used in patient care.

Up to 35% projected improvement in quality of life.
Up to 25% projected reduction in stroke-care costs through future digitally enabled pathways.
Up to 80% targeted reduction in procedural time